This is an extremely important point and I thought the exact same thing.
If Rem-l was looking like not going to be approved by the FDA they would not commit those large FDA resources to the MSB cause.
Ann: MSB Reports Q3 Financial Results and Operational Highlights, page-212
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.33 |
Change
0.040(3.11%) |
Mkt cap ! $1.524B | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.35 | $1.30 | $1.985M | 1.503M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 24953 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.33 | 6014 | 5 |
View Market Depth
| Last trade - 14.53pm 06/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |